Cognitive function in chronic obstructive pulmonary disease: Relationship to global initiative for chronic obstructive lung disease 2011 categories

Respirology

Volumn 19, Issue 6, 2014, Pages 873-880

  Tulek, Baykal ^a   Atalay, Nart Bedin ^b   Yildirim, Gulfem ^a   Kanat, Fikret ^a   Süerdem, Mecit ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b TOBB UNIVERSITY OF ECONOMICS AND TECHNOLOGY   (Turkey)

Author keywords

chronic obstructive pulmonary disease; cognitive function; exacerbation; Mini Mental State Examination

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; ATTENTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITION; COGNITIVE DEFECT; COORDINATION; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; AGED; CLASSIFICATION; COGNITION DISORDERS; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGY; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

AGED; C-REACTIVE PROTEIN; COGNITION; COGNITION DISORDERS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84904565551     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12333     Document Type: Article

References (39)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et-al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176: 532-555.
2. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, et-al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir. Res. 2010; 11: 122.
3. The Global Initiative for Chronic Obstructive Lung disease (GOLD). Revised 2011. [Accessed 1 Jun 2004.] Available from URL: www.goldcopd.com.
4. Barnes PJ, Celli BR,. Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 2009; 33: 1165-1185.
5. Dodd JW, Getov SV, Jones PW,. Cognitive function in COPD. Eur. Respir. J. 2010; 35: 913-922.
6. Schou L, Ostergaard B, Rasmussen LS, Rydahl-Hansen S, Phanareth K,. Cognitive dysfunction in patients with chronic obstructive pulmonary disease-a systematic review. Respir. Med. 2012; 106: 1071-1081.
7. Ortapamuk H, Naldoken S,. Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment. Ann. Nucl. Med. 2006; 20: 99-106.
8. Antonelli Incalzi R, Marra C, Giordano A, Calcagni ML, Cappa A, Basso S, Pagliari G, Fuso L,. Cognitive impairment in chronic obstructive pulmonary disease-a neuropsychological and spect study. J. Neurol. 2003; 250: 325-332.
9. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et-al. Standardisation of spirometry. Eur. Respir. J. 2005; 26: 319-338.
10. Folstein MF, Folstein SE, McHugh PR,. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975; 12: 189-198.
11. Gungen C, Ertan T, Eker E, Yasar R, Engin F,. Reliability and validity of the standardized Mini Mental State Examination in the diagnosis of mild dementia in Turkish population. Turk Psikiyatri Derg. 2002; 13: 273-281.
12. Cangoz B, Karakoc E, Selekler K,. Trail Making Test: normative data for Turkish elderly population by age, sex and education. J. Neurol. Sci. 2009; 283: 73-78.
13. Shulman KI,. Clock-drawing: is it the ideal cognitive screening test? Int. J. Geriatr. Psychiatry 2000; 15: 548-561.
14. Cangoz B, Karakoç E, Selekler K,. Saat çizme testi'nin Türk yetişkin ve yaşlbox drawings light down and left örneklemi üzerindeki norm belirleme ve geçerlik-güvenirlik çalbox drawings light down and leftşmalarbox drawings light down and left. Turk J Geriatr 2006; 9: 136-142.
15. Anil AE, Kivircik BB, Batur S, Kabakci E, Kitis A, Guven E, Başar K, Turgut TI, Arkar H,. The Turkish version of the Auditory Consonant Trigram Test as a measure of working memory: a normative study. Clin. Neuropsychol. 2003; 17: 159-169.
16. Cerhan JH, Ivnik RJ, Smith GE, Tangalos EC, Petersen RC, Boeve BF,. Diagnostic utility of letter fluency, category fluency, and fluency difference scores in Alzheimer's disease. Clin. Neuropsychol. 2002; 16: 35-42.
17. Ertan T, Eker E,. Reliability, validity, and factor structure of the Geriatric Depression Scale in Turkish elderly: are there different factor structures for different cultures? Int. Psychogeriatr. 2000; 12: 163-172.
18. Liesker JJ, Postma DS, Beukema RJ, ten Hacken NH, van der Molen T, Riemersma RA, van Zomeren EH, Kerstjens HA,. Cognitive performance in patients with COPD. Respir. Med. 2004; 98: 351-356.
19. Favalli A, Miozzo A, Cossi S, Marengoni A,. Differences in neuropsychological profile between healthy and COPD older persons. Int. J. Geriatr. Psychiatry 2008; 23: 220-221.
20. Hung WW, Wisnivesky JP, Siu AL, Ross JS,. Cognitive decline among patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2009; 180: 134-137.
21. Anzueto A,. Impact of exacerbations on COPD. Eur. Respir. Rev. 2010; 19: 113-118.
22. Wedzicha JA, Brill SE, Allinson JP, Donaldson GC,. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med. 2013; 11: 181.
23. Ambrosino N, Bruletti G, Scala V, Porta R, Vitacca M,. Cognitive and perceived health status in patient with chronic obstructive pulmonary disease surviving acute on chronic respiratory failure: a controlled study. Intensive Care Med. 2002; 28: 170-177.
24. Ranieri P, Bianchetti A, Margiotta A, Virgillo A, Clini EM, Trabucchi M,. Predictors of 6-month mortality in elderly patients with mild chronic obstructive pulmonary disease discharged from a medical ward after acute nonacidotic exacerbation. J. Am. Geriatr. Soc. 2008; 56: 909-913.
25. Kirkil G, Tug T, Ozel E, Bulut S, Tekatas A, Muz MH,. The evaluation of cognitive functions with P300 test for chronic obstructive pulmonary disease patients in attack and stable period. Clin. Neurol. Neurosurg. 2007; 109: 553-560.
26. Dodd JW, Charlton RA, van den Broek MD, Jones PW,. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest 2013; 144: 119-127.
27. Allen SC, Jain M, Ragab S, Malik N,. Acquisition and short-term retention of inhaler techniques require intact executive function in elderly subjects. Age Ageing 2003; 32: 299-302.
28. Incalzi RA, Gemma A, Marra C, Capparella O, Fuso L, Carbonin P,. Verbal memory impairment in COPD: its mechanisms and clinical relevance. Chest 1997; 112: 1506-1513.
29. Gan WQ, Man SF, Senthilselvan A, Sin DD,. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-580.
30. Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG,. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012; 186: 982-988.
31. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG,. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2007; 175: 250-255.
32. Sweat V, Starr V, Bruehl H, Arentoft A, Tirsi A, Javier E, Convit A,. C-reactive protein is linked to lower cognitive performance in overweight and obese women. Inflammation 2008; 31: 198-207.
33. Hoth KF, Haley AP, Gunstad J, Paul RH, Poppas A, Jefferson AL, Tate DF, Ono M, Jerskey BA, Cohen RA,. Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease. J. Am. Geriatr. Soc. 2008; 56: 1898-1903.
34. Gimeno D, Marmot MG, Singh-Manoux A,. Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study. Psychoneuroendocrinology 2008; 33: 1322-1334.
35. Xu G, Zhou Z, Zhu W, Fan X, Liu X, Plasma C-reactive protein is related to cognitive deterioration and dementia in patients with mild cognitive impairment. J. Neurol. Sci. 2009; 284: 77-80.
36. Marioni RE, Strachan MW, Reynolds RM, Lowe GD, Mitchell RJ, Fowkes FG, Frier BM, Lee AJ, Butcher I, Rumley A, et-al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010; 59: 710-713.
37. Bettcher BM, Wilheim R, Rigby T, Green R, Miller JW, Racine CA, Yaffe K, Miller BL, Kramer JH,. C-reactive protein is related to memory and medial temporal brain volume in older adults. Brain Behav. Immun. 2012; 26: 103-108.
38. Lal C, Strange C, Bachman D,. Neurocognitive impairment in obstructive sleep apnea. Chest 2012; 141: 1601-1610.
39. Tulek B, Atalay NB, Kanat F, Suerdem M,. Attentional control is partially impaired in obstructive sleep apnea syndrome. J. Sleep Res. 2013; 22: 422-429.